Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs

AIM: To evaluate the effect of an inhibitor of sodium-glucose cotransporter 2 (SGLT-2 inhibitor, dapagliflozin) on glycemic variability in type 2 diabetes mellitus (T2D) under insulin glargine combined with oral hypoglycemic drugs, using a continuous glucose monitoring system (CGMS). METHODS: This p...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Menghui, Kong, Xiaocen, Wang, Huiying, Zhai, Xiaofang, Cai, Tingting, Ding, Bo, Hu, Yun, Jing, Ting, Su, Xiaofei, Li, Huiqin, Ma, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707966/
https://www.ncbi.nlm.nih.gov/pubmed/33299890
http://dx.doi.org/10.1155/2020/6666403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707966/
https://www.ncbi.nlm.nih.gov/pubmed/33299890
http://dx.doi.org/10.1155/2020/6666403

Ejemplares similares